We are live on
!
Find out more
RAPP
Rapport Therapeutics
RAPP
RAPP
124 hedge funds and large institutions have $1.46B invested in Rapport Therapeutics in 2025 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
29.54% more ownership
Funds ownership: 105.47% → 135.01% (+30%)
17% more call options, than puts
Call options by funds: $7.6M | Put options by funds: $6.49M
Holders
124
Holding in Top 10
6
Calls
$7.6M
Puts
$6.49M
Top Buyers
| 1 | +$25.7M | |
| 2 | +$21.2M | |
| 3 | +$17.8M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$16.9M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$16.7M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$7.55M | |
| 3 | -$5.33M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.43M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.38M |